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IMPLEMENTATION OF AN OPIOID RISK ASSESSMENT TOOL IN AN ACUTE PAIN SERVICE
Emoshoke Owie, APRN, FNP-BC, DNP student
Georgia College and State University

BACKGROUND
Since 1999, opioids have claimed the lives of
more than 700,000 Americans; currently, this
amounts to an average of 130 every day (Tawil,
2019).

•
•

• Acute Pain Service
• Inpatient pain management services in a metro Atlanta acute care
hospital system.

PARTICIPANTS

• Purposive sampling
• Eleven providers
• Nurse Practitioners

The results from the 2017 National Survey on
Drug Use and Health, an estimated 2 million
Americans misused prescription pain relievers for
the first time within the past year (National
Institute on Drug Abuse, 2018).

INSTRUMENTS

• Risk Assessment tool; Diagnosis, Intractability, Risk, and Efficacy
• Acute Pain Service Rounding Sheet
• A post-implementation questionnaire survey (Survey Monkey® )

IMPLEMENTATION

Providers should screen patients for opioid abuse
and or misuse before starting long-term opioid
therapy.
No standardized risk assessment is done by the
Acute Pain Service(APS) providers.

CLINICAL QUESTIONS

The purpose of this quality improvement project
1. What are providers’ initial plans and final plans
was introduce the Diagnosis Intractability Risk
for initiating long-term opioid therapy (LTOT) in
Efficacy (DIRE); a risk assessment tool to be utilized
APS patients?
by Nurse Practitioners in an Acute Pain Service.
2. What is the relationship between providers’
initial plans and final plans for initiating LTOT?
The Acute Pain Service Manager identified the need
3. What is the relationship between patients’ risk
to assess patients for opioid risks before initiating
level and providers’ final plans for initiating
long-term opioid therapy. The risk for opioid
LTOT?
overdose increases significantly among patients
4.
What are providers’ initial plans and final plans
receiving long-term opioid therapy.
for patients' referral to an addiction specialist
(RAS)?
By utilizing this tool, patients inappropriate for
5. What is the relationship between providers’
long-term opioid therapy will be identified based
initial plans and final plans for patients' RAS?
on risk assessment scores.
6. What is the relationship between patients’ risk
level and providers' final plans for RAS?
Providers will make the appropriate
recommendations or referrals for the patient before 7. What is the percentage of the total number of
they leave the hospital
patients started on LTOT before and during the
project implementation according to the acute
pain rounding sheet?
8. What is the providers’ utilization of the DIRE at
two, four, six, eight, and ten weeks?
Emoshoke Owie, APRN, FNP-BC
9. What are providers’ perceptions regarding the
Georgia College and State University
DIRE tool after ten weeks of utilization?

CONTACT

Email:emoshoke.owie@bobcats.gcsu.edu

Descriptive mixed-method design
Quality improvement project

SETTING

In 2017, the United States government confirmed
the opioid crisis as a public health emergency
(Borsari & Read, 2019).

PURPOSE

PROJECT DESIGN

DIRE:OPIOID RISK TOOL

Before the Implementation of the DIRE
• APS rounding sheet review of number of patients that were
initiated on long-term opioids nine weeks before the project
implementation
• PowerPoint ® presentation to educate the NPs on how to use the
DIRE.
DIRE Implementation
• Respond to clinical decision questions before using the DIRE.
• Use the DIRE to screen any patient who has been referred for pain
management.
• Use and record the DIRE score
• Respond to clinical decision questions after using the DIRE
Clinical decision questions:
Would you initiate long-term opioids?
Would you refer to an addiction specialist?
After Project Implementation
• Post-implementation questionnaire
• APS rounding sheet review of number of patients that were
initiated on long-term opioids ten weeks during the project
implementation

RESULTS
• Providers’ initial and final plans for initiating long-term
opioid therapy were not significantly different.
• Patients with high DIRE risk levels were less likely to be
started on long-term opioids, and low DIRE risk levels
were more likely to be initiated on long-term opioids.
• Providers’ initial and final plans for referring Acute Pain
Service patients to an addiction specialist were not
statistically significantly different.
• Patients with high DIRE risk levels were more likely to
get a referral to an addiction specialist. Patients with
low DIRE risk levels were least likely to get a referral to
an addiction specialist.

RESULTS
• There was a 24.4% change in the number of long-term
opioids started nine weeks before and ten weeks
during the implementation.
• Providers thought the DIRE was helpful, easy to use,
straightforward, simple, and could be done in less than
3 minutes. One provider said, “I think using the DIRE is
A encouraging for providers to know that there are tools
out there to guide in safe decision-making regarding
managing pain.
• This research showed that the DIRE validated
providers' decisions to initiate long-term opioids or
refer the patient to an addiction specialist.

CONCLUSION
LIMITATIONS
• Small sample size
• Homogenous sample
• Convenience/Nonrandom sampling
FUTURE RESEARCH
• Larger sample size
• Extended study time
• Use of technology for data collection
• Use of other professionals
SUSTAINABILITY
• Electronic Medical Record
• Apple® DIRE app
• Periodic Reviews
IMPLICATIONS FOR PRACTICE
• Promotes patient safety
• Promotes safe prescribing practice
• Encourages screening in an acute care setting
• Encourages development of policies to standardize screening
in an acute care setting
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